Molecular Imaging of Active Mutant L858R EGF Receptor (EGFR) Kinase-Expressing Nonsmall Cell Lung Carcinomas Using PET/CT

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.1010744108
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Proceedings of the National Academy of Sciences

Related search

Molecular Imaging for Detection of Sensitivity and Resistance to EGFR Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer

Clinical and Translational Imaging
Nuclear MedicineRadiologyImaging
2014English

Hybrid Imaging (SPECT/ CT, PET/CT, PET/MR)

2016English

Composite Anatomical-Clinical-Molecular Prognostic Model in Nonsmall Cell Lung Cancer

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2010English

First-Line Treatment of EGFR-mutated Nonsmall Cell Lung Cancer: Critical Review on Study Methodology

European Respiratory Review
PulmonaryRespiratory Medicine
2014English

Planning Lung Radiation Therapy Incorporating Motion Freeze PET/CT Imaging

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2015English

PET-CT Hybrid Imaging

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2011English

Molecular Mechanisms of Acquired Resistance to Third-Generation EGFR-TKIs in EGFR T790m-Mutant Lung Cancer

Annals of Oncology
MedicineOncologyHematology
2019English

Erlotinib Resistance With EGFR L858r/Y891d Double Mutation in a Patient With Non–Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2019English

Correction To: Epidermal Growth Factor Receptor (EGFR)–Tyrosine Kinase Inhibitors (TKIs) Combined With Chemotherapy Delay Brain Metastasis in Patients With EGFR‑Mutant Lung Adenocarcinoma

Targeted Oncology
Cancer ResearchOncologyPharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy